Natriumklorid-Glucos, Viaflo Baxter (Sodium Chloride, Glucose)

Sodium chloride and glucose, the active ingredients in Natriumklorid-Glucos, Viaflo Baxter, is an IV electrolyte solution presented as an intravenous solution for intravenous use. It restores extracellular fluid volume, corrects electrolyte imbalances, and provides an energy substrate for patients requiring fluid therapy. GNH USA supplies Natriumklorid-Glucos, Viaflo Baxter as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals worldwide.

Natriumklorid-Glucos is used in clinical situations that require rapid fluid and electrolyte management. - Fluid replacement: rehydrates patients with acute volume loss and restores intravascular volume. - Electrolyte replenishment: corrects sodium and chloride deficits in dehydration or postoperative states. - Prevention or treatment of hypoglycemia: supplies glucose to raise blood sugar in patients at risk of low glucose levels.

Adverse reactions may occur with any intravenous therapy. Common Side Effects: - Infusion site irritation or pain - Mild hypernatremia - Transient hyperglycemia - Allergic skin reaction (rash or urticaria) - Nausea or vomiting - Headache Serious or Rare Side Effects: - Severe hypernatremia leading to neurological symptoms - Anaphylactic reaction requiring emergency treatment - Fluid overload causing pulmonary edema - Significant electrolyte imbalance resulting in cardiac arrhythmia - Hemolysis or renal impairment in susceptible patients

Careful assessment and monitoring are essential when administering this IV solution. - Assess fluid status: evaluate patient’s volume status before infusion. - Monitor electrolytes: check serum sodium and glucose levels regularly. - Use caution in renal impairment: adjust volume as needed. - Avoid rapid infusion in pediatric patients: infuse over recommended time. - Pregnancy and lactation: limited data, use only if benefit outweighs risk. - Store at 2-8°C: keep refrigerated, protect from light, do not freeze.

Potential drug interactions should be reviewed before therapy. Major Interactions (Avoid): - Hypertonic solutions: concurrent use may cause severe electrolyte shifts. - Insulin therapy: may potentiate hypoglycemia if glucose load is high. - Diuretics: increased risk of electrolyte imbalance. - Cardiac glycosides: altered serum sodium may affect drug levels. - Blood products: may cause incompatibility if mixed. Moderate Interactions (Monitor Closely): - ACE inhibitors: monitor blood pressure and potassium. - Beta‑blockers: watch for changes in heart rate with fluid shifts. - Corticosteroids: may increase sodium retention. - Antibiotics requiring renal dosing: adjust for fluid status. - Contrast media: monitor for additive nephrotoxicity.